For example, CIRT has been shown to reduce infiltration of immunosuppressive myeloid cells and M2 macrophages while enhancing M1 macrophages, CD8+ T cells, and NK cells across several murine tumor models [48–50]. Here, CD8A is linked to neoplasm.